NEW YORK, NY--(Marketwired - Jun 17, 2016) - Daxor Corporation (NYSE MKT: DXR), an investment company with medical
instrumentation and biotechnology operations, announces the hiring of Eric P. Coleman as its new Chief Financial Officer
effective June 6, 2016, reporting directly to Michael Feldschuh, Acting President & CEO of Daxor Corporation. "Mr. Coleman will
be responsible for overseeing the financial activities of Daxor and will help lead in the ongoing restructuring of the company as
well as negotiating joint ventures and corporate actions to enhance shareholder value in a transformative way," said Mr.
Feldschuh.
Eric is a licensed CPA and has more than 25 years of finance leadership experience, including tenures with high-profile
international public companies. His experience spans financial management and risk management in the technology sectors
complemented by several years in the manufacturing and medical device industries. He is passionate about improving processes to
increase market value and possesses a deep understanding of accounting, tax, payroll, and finance, in both large and small
enterprises. His knowledge of international settings and cultures gives him unique insight in working with diverse groups to
create effective, seamless, and high performing teams. He received his Bachelor's Degree in Accounting from Xavier
University.
Mr. Coleman stated, "I am thrilled to join Daxor. The strategic growth opportunities for the company are compelling, and the
mission of saving lives has never been more important. Daxor's BVA-100 Blood Volume Analyzer is a lifesaving diagnostic used at
leading hospitals in the country. I look forward to being an integral part of the team at Daxor and helping to drive further
success for the company."
Daxor Corporation manufactures and markets the BVA-100 Blood Volume Analyzer, which is used in conjunction with Volumex,
Daxor's single use diagnostic kit. For more information regarding Daxor Corporation's Blood Volume Analyzer BVA-100, visit
Daxor's website at www.Daxor.com.